Evidence map›Paper›PMID 28931083›Full record

ArticlePLoS pathogens2017

In vivo virulence of MHC-adapted AIDS virus serially-passaged through MHC-mismatched hosts.

Sayuri Seki, Takushi Nomura, Masako Nishizawa, Hiroyuki Yamamoto, Hiroshi Ishii, Saori Matsuoka, Teiichiro Shiino, Hironori Sato, Kazuta Mizuta, Hiromi Sakawaki and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Sayuri SekiAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Takushi NomuraAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Masako NishizawaAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Hiroyuki YamamotoAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Hiroshi IshiiAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Saori MatsuokaAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Teiichiro ShiinoAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6328-7262
Hironori SatoPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3746-4672
Kazuta MizutaInstitute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Hiromi SakawakiInstitute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Tomoyuki MiuraInstitute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
Taeko K NaruseMedical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Akinori KimuraMedical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Tetsuro MatanoAIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID http://orcid.org/0000-0003-3096-6749
National Institute of Infectious Diseases · JPKyoto University · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD8+ T-cell responses exert strong suppressive pressure on HIV replication and select for viral escape mutations. Some of these major histocompatibility complex class I (MHC-I)-associated mutations result in reduction of in vitro viral replicative capacity. While these mutations can revert after viral transmission to MHC-I-disparate hosts, recent studies have suggested that these MHC-I-associated mutations accumulate in populations and make viruses less pathogenic in vitro. Here, we directly show an increase in the in vivo virulence of an MHC-I-adapted virus serially-passaged through MHC-I-mismatched hosts in a macaque AIDS model despite a reduction in in vitro viral fitness. The first passage simian immunodeficiency virus (1pSIV) obtained 1 year after SIVmac239 infection in a macaque possessing a protective MHC-I haplotype 90-120-Ia was transmitted into 90-120-Ia- macaques, whose plasma 1 year post-infection was transmitted into other 90-120-Ia- macaques to obtain the third passage SIV (3pSIV). Most of the 90-120-Ia-associated mutations selected in 1pSIV did not revert even in 3pSIV. 3pSIV showed lower in vitro viral fitness but induced persistent viremia in 90-120-Ia- macaques. Remarkably, 3pSIV infection in 90-120-Ia+ macaques resulted in significantly higher viral loads and reduced survival compared to wild-type SIVmac239. These results indicate that MHC-I-adapted SIVs serially-transmitted through MHC-I-mismatched hosts can have higher virulence in MHC-I-matched hosts despite their lower in vitro viral fitness. This study suggests that multiply-passaged HIVs could result in loss of HIV-specific CD8+ T cell responses in human populations and the in vivo pathogenic potential of these escaped viruses may be enhanced.

Indexed as

AnimalsCD8-Positive T-LymphocytesHistocompatibility Antigens Class IImmune EvasionMacaca mulattaSimian Immunodeficiency VirusVirulenceHistocompatibility Antigens Class I

Identifiers

PMID28931083
PMCPMC5624644
OpenAlexW2755331449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.